U.S. AIR

Chiesi USA Appoints Richard Smith as Vice President and Business Unit Leader, U.S. AIR

Retrieved on: 
Monday, April 15, 2024
AIR, U.S. AIR, Chronic obstructive pulmonary disease, Health, Leo Pharma, History, Smith, Patient, Asthma, Organization, COPD

Chiesi USA remains steadfast in its preparations for the full-scale U.S. launch of its AIR franchise as part of the company’s commitment to improving respiratory care and health in communities

Key Points: 
  • Chiesi USA remains steadfast in its preparations for the full-scale U.S. launch of its AIR franchise as part of the company’s commitment to improving respiratory care and health in communities
    CARY, N.C., April 15, 2024 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced it has appointed Richard Smith as vice president and business unit leader of U.S. AIR.
  • Smith will report to Jon Zwinski, CEO and general manager of Chiesi USA.
  • “Richard’s inspirational leadership and track record of enabling actionable programs with multistakeholder engagement reflect Chiesi USA’s mission and values.
  • Before joining Chiesi USA, Smith was vice president and head of the U.S. commercial organization at LEO Pharma, Inc.